1987
Loss of myeloid differentiation antigens precedes blastic transformation in chronic myelogenous leukemia.
Todd M, Waldron J, Jennings T, Rome L, Markowitz S, Holford T, Gardner J, Wolak J, Malech H. Loss of myeloid differentiation antigens precedes blastic transformation in chronic myelogenous leukemia. Blood 1987, 70: 122-31. PMID: 2439147, DOI: 10.1182/blood.v70.1.122.bloodjournal701122.Peer-Reviewed Original ResearchConceptsBone marrow biopsy samplesBone marrow biopsy specimensBone marrow biopsyAntigen-positive cellsMarrow biopsy specimensChronic myelogenous leukemiaBlast crisisBiopsy specimensBone marrow cellsBiopsy samplesBlast transformationMyeloid antigensChronic phaseMarrow biopsyDisease progressionMyelogenous leukemiaMarrow cellsImpending blast crisisMyeloid differentiation antigensHuman neutrophil antigensPatient 1Neutrophil antigensBlastic crisisBlastic transformationIndirect immunoperoxidaseLoss of myeloid differentiation antigens precedes blastic transformation in chronic myelogenous leukemia
Todd M, Waldron J, Jennings T, S. R, D. M, R. H, Gardner J, Wolak J, Malech H. Loss of myeloid differentiation antigens precedes blastic transformation in chronic myelogenous leukemia. Blood 1987, 70: 122-131. DOI: 10.1182/blood.v70.1.122.122.Peer-Reviewed Original ResearchBone marrow biopsy samplesBone marrow biopsy specimensBone marrow biopsyAntigen-positive cellsMarrow biopsy specimensChronic myelogenous leukemiaBlast crisisBiopsy specimensBone marrow cellsBiopsy samplesBlast transformationMyeloid antigensChronic phaseMarrow biopsyDisease progressionMyelogenous leukemiaMarrow cellsImpending blast crisisMyeloid differentiation antigensHuman neutrophil antigensPatient 1Neutrophil antigensBlastic crisisBlastic transformationIndirect immunoperoxidase
1985
Risk Factors for Fibrocystic Breast Disease and Its Histopathologic Components2
Berkowitz G, Kelsey J, LiVolsi V, Holford T, Merino M, Ort S, O'Connor T, White C. Risk Factors for Fibrocystic Breast Disease and Its Histopathologic Components2. Journal Of The National Cancer Institute 1985, 75: 43-50. PMID: 3859695, DOI: 10.1093/jnci/75.1.43.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseBenign breast diseaseBreast diseaseHigher socioeconomic statusOdds ratioLow Quetelet's indexSocioeconomic statusBreast cancer patientsCase-control studyEpidemiologic similaritiesCurrent smokersPostmenopausal womenPremenopausal womenEpithelial atypiaGross cystsFibrocystic diseaseCancer patientsPapillary hyperplasiaQuetelet indexBiopsy specimensRisk factorsSurgical conditionsConnecticut hospitalsLow parityBreast cancerAN EPIDEMIOLOGIC STUDY OF FIBROCYSTIC BREAST DISEASE WITH REFERENCE TO DUCTAL EPITHELIAL ATYPIA
PASTIDES H, KELSEY J, HOLFORD T, LIVOLSI V. AN EPIDEMIOLOGIC STUDY OF FIBROCYSTIC BREAST DISEASE WITH REFERENCE TO DUCTAL EPITHELIAL ATYPIA. American Journal Of Epidemiology 1985, 121: 440-447. PMID: 4014134, DOI: 10.1093/oxfordjournals.aje.a114016.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseDuctal epithelial atypiaCase-control studyBreast diseaseDuctal atypiaEpithelial atypiaMinimal atypiaBreast cancerFirst-degree female relativesBreast biopsy specimensRecent checkupSurgical menopauseEpidemiologic characteristicsFirst pregnancyBiopsy specimensRisk factorsEpidemiologic studiesAtypiaCheckupAtypia scoreFrequent checkupsBreast lesionsDiseaseFemale relativesOnly variable
1984
Exogenous hormone use and fibrocystic breast disease by histopathologic component
Berkowitz G, Kelsey J, Livolsi V, Merino M, Holford T, Hildreth N, Ort S, O'Connor T, White C. Exogenous hormone use and fibrocystic breast disease by histopathologic component. International Journal Of Cancer 1984, 34: 443-449. PMID: 6490201, DOI: 10.1002/ijc.2910340403.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseEstrogen replacement therapyBreast diseaseGross cystsReplacement therapyHospital-based case-control studyExogenous hormone useOral contraceptive usePost-menopausal womenCase-control studyPostmenopausal womenPremenopausal womenHormone useOral contraceptivesEpithelial atypiaControl womenPapillary hyperplasiaBiopsy specimensFibrocystic lesionsSurgical conditionsContraceptive useHistopathologic componentsWomenIncreased occurrenceDisease
1983
Oral Contraceptive Use and Fibrocystic Breast Disease With Special Reference to Its Histopathology23
Pastides H, Kelsey J, LiVolsi V, Holford T, Fischer D, Goldenberg I. Oral Contraceptive Use and Fibrocystic Breast Disease With Special Reference to Its Histopathology23. Journal Of The National Cancer Institute 1983, 71: 5-9. PMID: 6575209, DOI: 10.1093/jnci/71.1.5.Peer-Reviewed Original ResearchConceptsOral contraceptive useFibrocystic breast diseaseOral contraceptivesContraceptive useBiopsy specimensBreast diseaseHospital-based case-control studyCase-control studyHigh atypiaEpithelial atypiaGross cystsHistopathologic characteristicsFibrocystic diseaseAtypiaContraceptivesDiseaseMicroscopic cystsCystsNew HavenSimilar patternPapillomatosisHistopathologySpecial referenceCasesControl